Responsive Neurostimulation for Drug-Resistant Epilepsy

Responsive neurostimulation (RNS) is an implantable therapy for patients whose focal epilepsy remains refractory to antiepileptic drugs. Electrodes are placed at putative seizure foci and continuously monitor intracranial electrical activity, delivering brief pulses of stimulation in response to detected abnormalities. Clinical trials and long-term registries have demonstrated substantial reductions in median seizure frequency, with benefits accruing over several years, alongside improvements in quality of life. Despite this, individual responses vary markedly, prompting investigation into network-level mechanisms and device parameters. Emerging evidence suggests that efficacy may not solely depend on direct targeting of the seizure focus or on purely reactive stimulation, but also on modulation of broader cortical and subcortical networks. Advances in neurophysiological analytics, connectivity mapping and closed-loop algorithms are refining patient selection, electrode placement and stimulation protocols. Together, these developments herald a shift from empirical implantation towards personalised neuromodulation strategies capable of improving outcomes in drug-resistant epilepsy worldwide.

Research from Nature Portfolio

Recent studies have re-evaluated fundamental hypotheses of responsive neurostimulation. Analysis of large patient cohorts questions the long-held assumptions that leads must strictly target the seizure focus and that stimulation should occur only after detection of epileptiform discharges. These investigations propose alternative strategies, such as proactive or distributed stimulation paradigms and network-informed lead configurations. Such insights are guiding refinements in patient stratification, electrode implantation sites and device programming to maximise seizure control.

Responsive Neurostimulation for Drug-Resistant Epilepsy publication trend

The graph below shows the total number of articles in responsive neurostimulation for drug-resistant epilepsy across all publications each year (not limited to Nature Index journals).

Technical terms

Responsive neurostimulation: An implantable closed-loop system that detects abnormal brain activity and delivers electrical stimulation to suppress seizures.

Seizure onset zone: The region of the brain where seizure activity originates.

Electrocorticography (ECoG): Recording of electrical activity from the cortical surface via implanted electrodes.

Functional connectivity: Statistical relationships between spatially distinct neural regions, often inferred from synchronised activity patterns.

Cortico-cortical evoked potentials (CCEPs): Electrical responses in one cortical region elicited by single-pulse stimulation of another, used to assess effective connectivity.

References

1. Unearthing the mechanisms of responsive neurostimulation for epilepsy. Communications Medicine (2023).
2. Effective connectivity relates seizure outcome to electrode placement in responsive neurostimulation. Brain Communications (2023).
3. Network connectivity predicts effectiveness of responsive neurostimulation in focal epilepsy. Brain Communications (2022).
4. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology (2015).
5. Acute effects of brain-responsive neurostimulation in drug-resistant partial onset epilepsy. Clinical Neurophysiology (2021).
6. A Rational Approach to Understanding and Evaluating Responsive Neurostimulation. Neuroinformatics (2020).